<DOC>
	<DOCNO>NCT01422837</DOCNO>
	<brief_summary>The objective VIVITROL Registry gather real world data opioid dependence provide understand health economics opioid dependence .</brief_summary>
	<brief_title>ALK21-025 : Vivitrol 's Cost Treatment Outcomes Registry</brief_title>
	<detailed_description>The VIVITROL Registry observational , open-label , single-arm , multi-center registry patient initiated treatment VIVITROL prevention relapse opioid dependence , follow opioid detoxification . The objective VIVITROL Registry : - To describe characteristic patient receive VIVITROL opioid dependence real-world clinical practice . - To assess clinical , health economic , health-related quality life ( HRQOL ) outcomes broad population patient receive VIVITROL real-world clinical practice . - To provide additional data inform future research VIVITROL . Patients 18 year age old determine participate prescriber appropriate candidate VIVITROL treatment may offer enrollment registry . The decision treat patient VIVITROL make patient 's participate prescriber independent registry . VIVITROL provide patient enrol registry exchange participation ; patient receive commercially available VIVITROL via standard prescription fill standard commercial channel . Patients observe receive VIVITROL six month discontinue VIVITROL use . The registry non-interventional ; neither direct treatment plan enrol patient define frequency follow-up visit patient . A patient 's participation registry influence direct patient treatment procedures follow-up care . It expect patient see least per month active VIVITROL treatment receive monthly injection . During standard monthly injection visit , patient ask provide detailed health economics information use variety questionnaire , include EQ-5D SF-12v2 .</detailed_description>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Patient age 18 year old Patient diagnose current opioid dependence treatment VIVITROL initiate Patient provide write informed consent Patient willing able provide information collect via registry 's interview questionnaires Patient expect available ongoing registry participation Prior use VIVITROL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>opioid</keyword>
	<keyword>dependence</keyword>
	<keyword>VIVITROL</keyword>
</DOC>